Carisma Therapeutics, Inc.
News
Carisma Therapeutics expands cell therapy collaboration with Moderna
Bizjournals.com - Health Care News The firm will receive additional research funding from Moderna and be eligible for additional milestone and royalty payments.\n more…
Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases
PR Newswire Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune...\n more…
Carisma Therapeutics to Present at Upcoming Conferences
PR Newswire Carisma Therapeutics to Present at Upcoming Conferences Carisma Therapeutics to Present at Upcoming Conferences PR Newswire PHILADELPHIA, Sept. 3, 2024 PHILADELPHIA, Sept. 3, 2024 /PRNewswire...\n more…
Companies Like Carisma Therapeutics (NASDAQ:CARM) Could Be Quite Risky
Simply Wall St We can readily understand why investors are attracted to unprofitable companies. For example, although...\n more…
Head to Head Comparison: Carisma Therapeutics (NASDAQ:CARM) versus GlobeImmune (OTCMKTS:GBIM)
Ticker Report GlobeImmune (OTCMKTS:GBIM - Get Free Report) and Carisma Therapeutics (NASDAQ:CARM - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies...\n more…